Evidence mapPaperPMID 25027581Full record

ArticleBMC health services research2014

Clinically relevant quality measures for risk factor control in primary care: a retrospective cohort study.

Stefan Weiler, Armin Gemperli, Tinh-Hai Collet, Douglas C Bauer, Lukas Zimmerli, Jacques Cornuz, Edouard Battegay, Jean-Michel Gaspoz, Eve A Kerr, Drahomir Aujesky and 1 more

Abstract read
In one paragraph

Article in BMC health services research, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Pay for performance and the management of hypertension.Journal of translational internal medicine · 2016
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Stefan Weiler
Armin Gemperli
Tinh-Hai Collet
Douglas C Bauer
Lukas Zimmerli
Jacques Cornuz
Edouard Battegay
Jean-Michel Gaspoz
Eve A Kerr
Drahomir Aujesky
Nicolas RodondiDepartment of General Internal Medicine, University of Bern, Bern, Switzerland. nicolas.rodondi@insel.ch.

Funding

Biomarker Research in Musculoskeletal DiseaseK24AR051895 · UNIVERSITY OF CALIFORNIA SAN FRANCISCO · 2005 to 2005
$119k
NIAMS NIH HHS K24 AR051895
6 · The paper itself

Abstract

backgroundAssessment of the proportion of patients with well controlled cardiovascular risk factors underestimates the proportion of patients receiving high quality of care. Evaluating whether physicians respond appropriately to poor risk factor control gives a different picture of quality of care. We assessed physician response to control cardiovascular risk factors, as well as markers of potential overtreatment in Switzerland, a country with universal healthcare coverage but without systematic quality monitoring, annual report cards on quality of care or financial incentives to improve quality.

methodsWe performed a retrospective cohort study of 1002 randomly selected patients aged 50-80 years from four university primary care settings in Switzerland. For hypertension, dyslipidemia and diabetes mellitus, we first measured proportions in control, then assessed therapy modifications among those in poor control. "Appropriate clinical action" was defined as a therapy modification or return to control without therapy modification within 12 months among patients with baseline poor control. Potential overtreatment of these conditions was defined as intensive treatment among low-risk patients with optimal target values.

results20% of patients with hypertension, 41% with dyslipidemia and 36% with diabetes mellitus were in control at baseline. When appropriate clinical action in response to poor control was integrated into measuring quality of care, 52 to 55% had appropriate quality of care. Over 12 months, therapy of 61% of patients with baseline poor control was modified for hypertension, 33% for dyslipidemia, and 85% for diabetes mellitus. Increases in number of drug classes (28-51%) and in drug doses (10-61%) were the most common therapy modifications. Patients with target organ damage and higher baseline values were more likely to have appropriate clinical action. We found low rates of potential overtreatment with 2% for hypertension, 3% for diabetes mellitus and 3-6% for dyslipidemia.

conclusionsIn primary care, evaluating whether physicians respond appropriately to poor risk factor control, in addition to assessing proportions in control, provide a broader view of the quality of care than relying solely on measures of proportions in control. Such measures could be more clinically relevant and acceptable to physicians than simply reporting levels of control.

Indexed as

Quality Indicators, Health CareAgedAged, 80 and overCardiovascular DiseasesComorbidityFemaleHumansMaleMiddle AgedPrimary Health CareRetrospective StudiesRisk FactorsSwitzerland

Identifiers

PMID25027581
PMCPMC4105792

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.